Indoco Remedies Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|
| Revenue | 353.75 | 378.23 | 400.73 |
| Operating Expense | 343.79 | 352.84 | 343.66 |
| Net Profit | -26.24 | -10.23 | 12.79 |
| Net Profit Margin | -7.42 | -2.70 | 3.19 |
| Earning Per Share | -2.85 | -1.11 | 1.39 |
| EBIDTA | 11.69 | 23.48 | 55.72 |
| Effective Tax Rate | -29.42 | -19.85 | 5.68 |
| Particulars | Mar 2025 |
|---|---|
| Revenue | 353.75 |
| Operating Expense | 343.79 |
| Net Profit | -26.24 |
| Net Profit Margin | -7.42 |
| Earning Per Share | -2.85 |
| EBIDTA | 11.69 |
| Effective Tax Rate | -29.42 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Total Revenue Annual | 1,790.81 | 1,666.69 | 1,539.72 |
| Operating Expenses Annual | 1,532.82 | 1,381.80 | 1,212.72 |
| Operating Profit Annual | 278.02 | 287.22 | 329.32 |
| Interest Annual | 36.81 | 25.03 | 14.14 |
| Depreciation | 57.94 | 54.41 | 49.13 |
| Net Profit Annual | 116.64 | 141.36 | 154.52 |
| Tax Annual | 36.58 | 50.23 | 81.71 |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | 1,790.81 |
| Operating Expenses Annual | 1,532.82 |
| Operating Profit Annual | 278.02 |
| Interest Annual | 36.81 |
| Depreciation | 57.94 |
| Net Profit Annual | 116.64 |
| Tax Annual | 36.58 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | 9.99 | 16.90 | 9.13 |
| Cash Flow from Operations | 176.78 | 178.79 | 173.55 |
| Cash Flow from Investing | -301.70 | -208.51 | -121.41 |
| Cash Flow from Financing | 122.40 | 22.81 | -44.37 |
| Cash Flow at the End | 7.47 | 9.99 | 16.90 |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | 9.99 |
| Cash Flow from Operations | 176.78 |
| Cash Flow from Investing | -301.70 |
| Cash Flow from Financing | 122.40 |
| Cash Flow at the End | 7.47 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| PBDIT Margin (%) | 15.52 | 17.23 | 21.39 |
| PBIT Margin (%) | 10.61 | 13 | 16.26 |
| PBT Margin (%) | 10.32 | 12.48 | 15.11 |
| Net PROFIT Margin (%) | 6.51 | 8.48 | 10.04 |
| Return On Networth / Equity (%) | 10.83 | 14.64 | 18.47 |
| Return On Networth /Employed (%) | 12.31 | 16.66 | 22.05 |
| Return On Assets (%) | 7.56 | 10.86 | 13.65 |
| Total Debt / Equity (X) | 0.39 | 0.31 | 0.31 |
| Asset Turnover Ratio (%) | 1.16 | 1.28 | 1.36 |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | 15.52 |
| PBIT Margin (%) | 10.61 |
| PBT Margin (%) | 10.32 |
| Net PROFIT Margin (%) | 6.51 |
| Return On Networth / Equity (%) | 10.83 |
| Return On Networth /Employed (%) | 12.31 |
| Return On Assets (%) | 7.56 |
| Total Debt / Equity (X) | 0.39 |
| Asset Turnover Ratio (%) | 1.16 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | 754.28 | 719.66 | 623.70 |
| Total Current Assets Annual | 900.21 | 812.47 | 772.78 |
| Non Current Assets Annual | 1,060.39 | 847.21 | 714.79 |
| Total Shareholders Funds Annual | 1,126.62 | 1,027.02 | 904.30 |
| Total Assets Annual | 1,960.61 | 1,659.67 | 1,487.57 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | 754.28 |
| Total Current Assets Annual | 900.21 |
| Non Current Assets Annual | 1,060.39 |
| Total Shareholders Funds Annual | 1,126.62 |
| Total Assets Annual | 1,960.61 |
EPS (INR)
Expected
0.00
Reported
-4.48
Surprise
0.00%
Dec 2024
EPS beaten by 0.00%
Sep 2024
EPS beaten by 0.00%
Jun 2024
EPS beaten by 0.00%
